Excel Semaglutide and Tirzepatide are advanced peptides developed for weight management and metabolic research. Tirzepatide, also known as LY3298176, functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It has demonstrated superior efficacy in glucose control and weight reduction compared to other treatments like Dulaglutide.
Excel Semaglutide is a key compound in this category, offering high purity and stability for research applications. It is particularly noted for its role in weight loss studies, where it helps achieve significant reductions in body weight and BMI when combined with diet and exercise. The product is supplied as a white powder with a purity of 99%, ensuring reliable results in laboratory settings.
These peptides are stored under recommended conditions to maintain integrity. For optimal solubility, it is advised to warm the solution to 37°C and use ultrasonic agitation. Stock solutions can be stored at -20°C for extended periods without degradation.
Excel Semaglutide and Tirzepatide are intended for research use only and are not for personal consumption. They are ideal for pharmaceutical development, clinical studies, and other scientific investigations focused on metabolic health and weight management.